![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
FAVOURABLE OUTCOME of IN VITRO SELECTIONS WITH NOVEL NRTI PRODRUG GS-9131
|
|
|
Reported by Jules Levin
CROI 2019 March 4-7 Seattle
Ruxandra-Ilinca Ibanescu1, Maureen Oliviera1, Bonnie Spira1, Jean-Pierre Routy2, Bluma G. Brenner2 and Montreal Primary HIV (PHI) Cohort Study Group.
1Lady Davis Institute for Medical Research, Montreal, QC, Canada, 2McGill University, Montreal, QC, Canada
![0314191](../images/031418/031419-5/0314191.gif)
![0314192](../images/031418/031419-5/0314192.gif)
![0314193](../images/031418/031419-5/0314193.gif)
![0314194](../images/031418/031419-5/0314194.gif)
![0314195](../images/031418/031419-5/0314195.gif)
![0314196](../images/031418/031419-5/0314196.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|